The COVID Project
The record
- Jurisdiction
- United States
- Level
- Federal
- Authority
- Defense Production Act title III (50 U.S.C. §§ 4531-4533)
- Issued
- 2020-03-27 Mar. 27, 2020
- Effective
- 2020-03-27
- End
- for the duration of the national emergency (read as 2021-09-30)
- In force
- Mar. 27, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Supply chain
- Addressees
- the Secretaries of HHS and Homeland Security
- Functions reached
- SC (federal direction of medical-supply production and purchasing)
- PF manufacturing (title III contracts)
- Collection
- Federal health, safety and transport layer FED-A
Operative words
Sec. 2. Delegation of Authority Under Title III of the Act. (a) Notwithstanding Executive Order 13603 of March 16, 2012 (National Defense Resources Preparedness), the Secretary of Health and Human Services and the Secretary of Homeland Security are each delegated, with respect to responding to the spread of COVID-19 within the United States, the authority of the President conferred by sections 301, 302, and 303 of the Act (50 U.S.C. 4531, 4532, and 4533)
Enforcement
DPA title III (purchases, purchase commitments, installation of equipment in private plants)
Notes
Basis for the federal ventilator, mask and testing-supply production directives of 2020 (General Motors, 3M, etc.).